2012 Health Care Heroes: Douglas J. Schwartzentruber, M.D.

Back to TopCommentsE-mailPrintBookmark and Share

Health Care HeroesFINALIST: Advancements in Health Care

Douglas J. Schwartzentruber, M.D.

System Medical Director of Indiana University Health Cancer Services; Associate Director of Clinical Affairs at IU Simon Cancer Center


A therapeutic vaccine for advanced melanoma patients combined with an immune-boosting drug scored promising results in a large clinical trial published in the New England Journal of Medicine last June 2. Researchers saw tumors shrink significantly and stay progression-free longer with the vaccine and interleukin-2, than with the drug alone.

Schwartzentruber_Doug_AdvHC.jpg (IBJ Photo/ Perry Reichanadter)

Douglas J. Schwartzentruber, M.D., lead author of the study, now serves as system medical director of IU Health Cancer Services. “This is proof of principle that vaccines can work to treat metastatic melanoma. The trial was one of the first of its kind, and the first to show a benefit of a peptide vaccine,” said Schwartzentruber, 55. A peptide is a small portion of a protein that is present on the surface of melanoma cancer cells.

Most vaccines are preventative. This melanoma vaccine is therapeutic, meant to boost the immune system enough to battle existing tumors.

The randomized Phase 3 clinical trial included 185 patients with metastatic melanoma at 21 care centers throughout the country. One group received the vaccine, along with interleukin-2, a drug that empowers the immune system. A second group only received interleukin-2.

Patients who received both the melanoma vaccine and drug did better than those who only got interleukin-2. Researchers saw tumors shrink 50 percent or more in 16 percent of the study population who received the vaccine and drug, compared to six percent with just interleukin-2.

Tumors grew slower when patients received the vaccine and drug. With the combination, tumors stopped growing for 2.2 months compared to 1.6 months with just interleukin-2. While the study was not designed to track survival rates, the median overall survival rate for those receiving the vaccine was 17.8 months versus 11.1 months. 

Before the trial, Schwartzentruber spent 16 years at the National Cancer Institute, the largest institute of the National Institutes of Health. He started as a fellow then moved up to senior investigator in the surgery branch, which studied melanoma.

Steven A. Rosenberg, M.D., PhD, surgery branch chief of the NCI, “taught me the research method and appreciation for melanoma. He’s the reason I pursued melanoma as a career. He also taught me how to deliver bad news to patients in a compassionate way,” Schwartzentruber said.

CA: A Cancer Journal for Clinicians recently reported a significant decline in overall cancer deaths in the last 20 years, but melanoma incidence and deaths have increased, and are expected to rise. Schwartzentruber’s research opens the door for vaccine treatments not only for melanoma, but other cancers as well.

His groundbreaking results were first presented during the American Society of Clinical Oncology conference in 2009, earning him recognition in 2010 on Time magazine’s annual list of the 100 most influential people in the world. 

Time hosted a red carpet affair in New York City that Schwartzentruber and his wife of 25 years, Diane White, attended. The magazine divides its “most influential” list into four categories: leaders, artists, thinkers and heroes. Time recognized Schwartzentruber in the thinkers category.

What’s next? The vaccine isn’t ready yet. It will be improved, there will be further study, and eventually it will go to market, Schwartzentruber said.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. Apologies for the wall of text. I promise I had this nicely formatted in paragraphs in Notepad before pasting here.

  2. I believe that is incorrect Sir, the people's tax-dollars are NOT paying for the companies investment. Without the tax-break the company would be paying an ADDITIONAL $11.1 million in taxes ON TOP of their $22.5 Million investment (Building + IT), for a total of $33.6M or a 50% tax rate. Also, the article does not specify what the total taxes were BEFORE the break. Usually such a corporate tax-break is a 'discount' not a 100% wavier of tax obligations. For sake of example lets say the original taxes added up to $30M over 10 years. $12.5M, New Building $10.0M, IT infrastructure $30.0M, Total Taxes (Example Number) == $52.5M ININ's Cost - $1.8M /10 years, Tax Break (Building) - $0.75M /10 years, Tax Break (IT Infrastructure) - $8.6M /2 years, Tax Breaks (against Hiring Commitment: 430 new jobs /2 years) == 11.5M Possible tax breaks. ININ TOTAL COST: $41M Even if you assume a 100% break, change the '30.0M' to '11.5M' and you can see the Company will be paying a minimum of $22.5, out-of-pocket for their capital-investment - NOT the tax-payers. Also note, much of this money is being spent locally in Indiana and it is creating 430 jobs in your city. I admit I'm a little unclear which tax-breaks are allocated to exactly which expenses. Clearly this is all oversimplified but I think we have both made our points! :) Sorry for the long post.

  3. Clearly, there is a lack of a basic understanding of economics. It is not up to the company to decide what to pay its workers. If companies were able to decide how much to pay their workers then why wouldn't they pay everyone minimum wage? Why choose to pay $10 or $14 when they could pay $7? The answer is that companies DO NOT decide how much to pay workers. It is the market that dictates what a worker is worth and how much they should get paid. If Lowe's chooses to pay a call center worker $7 an hour it will not be able to hire anyone for the job, because all those people will work for someone else paying the market rate of $10-$14 an hour. This forces Lowes to pay its workers that much. Not because it wants to pay them that much out of the goodness of their heart, but because it has to pay them that much in order to stay competitive and attract good workers.

  4. GOOD DAY to you I am Mr Howell Henry, a Reputable, Legitimate & an accredited money Lender. I loan money out to individuals in need of financial assistance. Do you have a bad credit or are you in need of money to pay bills? i want to use this medium to inform you that i render reliable beneficiary assistance as I'll be glad to offer you a loan at 2% interest rate to reliable individuals. Services Rendered include: *Refinance *Home Improvement *Inventor Loans *Auto Loans *Debt Consolidation *Horse Loans *Line of Credit *Second Mortgage *Business Loans *Personal Loans *International Loans. Please write back if interested. Upon Response, you'll be mailed a Loan application form to fill. (No social security and no credit check, 100% Guaranteed!) I Look forward permitting me to be of service to you. You can contact me via e-mail howellhenryloanfirm@gmail.com Yours Sincerely MR Howell Henry(MD)

  5. It is sad to see these races not have a full attendance. The Indy Car races are so much more exciting than Nascar. It seems to me the commenters here are still a little upset with Tony George from a move he made 20 years ago. It was his decision to make, not yours. He lost his position over it. But I believe the problem in all pro sports is the escalating price of admission. In todays economy, people have to pay much more for food and gas. The average fan cannot attend many events anymore. It's gotten priced out of most peoples budgets.